Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Tamara L. Lotan(Johns Hopkins University), Jeremy A. Squire(Universidade de São Paulo)
Cited by 90
Related Papers
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
|Clinical Cancer Research|2011|350
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
|Modern Pathology|2018|100
mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation
|Journal of Clinical Investigation|2017|40
Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer
|Cancer|2022|32
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images
|Modern Pathology|2023|25